A Phase I, Multi-Center, Open-Label, Dose Escalation Study of Thrombosomes in Bleeding Thrombocytopenic Patients in Three Cohorts
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2019
Price : $35 *
At a glance
- Drugs Thrombosomes (Primary)
- Indications Haemorrhage
- Focus Adverse reactions
- Sponsors Cellphire
- 10 Jul 2019 Planned End Date changed from 18 Jun 2019 to 18 Oct 2019.
- 10 Jul 2019 Planned primary completion date changed from 18 Jun 2019 to 3 Aug 2019.
- 10 Jul 2019 Status changed from recruiting to active, no longer recruiting.